Global Cord Blood Corporation (CORBF)
ValueMarkers Composite Index
97% below intrinsic value ($6)
Global Cord Blood Corporation (CORBF) — VMCI valuation read
CORBF prints VMCI 69/100 inside the Healthcare sector, where the median sits at 50. The 19-point above-median delta is the cleanest single-number summary of Global Cord Blood Corporation's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On CORBF, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** CORBF trades at 24.0x earnings, 33% above the Healthcare median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -2.0x leaves covenant headroom; that is the risk line for Global Cord Blood Corporation on the trailing financials.
CORBF rose 0.2% over the trailing 7 days, with a -14.5% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.